<DOC>
	<DOCNO>NCT01198327</DOCNO>
	<brief_summary>This study evaluate long-term safety patient macular edema due Retinal Vein Occlusion ( RVO ) originally enrol BRAVO &amp; CRUISE trials subsequently follow HORIZON extension trial .</brief_summary>
	<brief_title>Extended Follow-up Patients With Macular Edema Due Retinal Vein Occlusion</brief_title>
	<detailed_description>There strong evidence ranibizumab provide benefit subject macular edema due RVO ; however , subject require continued injection year maintain benefit . It likely subject continue production VEGF ( Vascular Endothelial Growth Factor ) area nonperfused retina periphery . One strategy perform scatter photocoagulation area nonperfusion reduce continue production VEGF , important know visual benefit maintain do , , would better continue intermittent injection ranibizumab .</detailed_description>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Retinal Vein Occlusion</mesh_term>
	<mesh_term>Ranibizumab</mesh_term>
	<criteria>Signed informed consent authorization use disclosure protect health information Age great equal 18 year Completion 12 month BRAVO CRUISE trial , subsequent followup HORIZON extension study . Exit HORIZON within 90 day enrollment Pregnancy ( positive pregnancy test ) lactation Premenopausal woman use adequate contraception . The following consider effective mean contraception : surgical sterilization use oral contraceptive , barrier contraception either condom diaphragm conjunction spermicidal gel , IUD , contraceptive hormone implant patch . Any condition investigator believe would pose significant hazard subject investigational therapy initiate . Inability comply study follow procedure Participation another simultaneous medical investigation trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>RVO</keyword>
	<keyword>CRVO</keyword>
	<keyword>BRVO</keyword>
	<keyword>Horizon</keyword>
	<keyword>Bravo</keyword>
	<keyword>Cruise</keyword>
</DOC>